ArticleAmyotrophic lateral sclerosis & frontotemporal degeneration2022
Defining cognitive impairment in amyotrophic lateral sclerosis: an evaluation of empirical approaches.
Open access · bronzeAbstract read
In one paragraph
Article in Amyotrophic lateral sclerosis & frontotemporal degeneration, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
4.6field-weighted citation impact, top 4% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 39 citations in OpenAlex.
- ECAS-Based Neuropsychological Phenotyping in Amyotrophic Lateral Sclerosis: A Retrospective Study Comparing Different Algorithms.Neurology and therapy · 2026Article
- Alzheimer's Disease Co-Pathology and Cognitive Impairment in Amyotrophic Lateral Sclerosis.Annals of neurology · 2026Article
- Decoding Neuroinflammatory Pathways: The Role of the CXCL12-CXCR4/CXCR7 Axis in ALS-Related Cognitive Impairment.Molecular neurobiology · 2026Review
- Brain Folding Trajectories in Amyotrophic Lateral Sclerosis.Human brain mapping · 2026Article
- Data-driven disease subgrouping in ALS: a multicenter cerebral functional connectivity study.Journal of neurology · 2026Article
- Multimodal Neuroimaging-Guided Stratification in Amyotrophic Lateral Sclerosis Reveals Three Disease Subtypes: A Multi-Cohort Analysis.Human brain mapping · 2025Article
- Regional Cerebral Atrophy Contributes to Personalized Survival Prediction in Amyotrophic Lateral Sclerosis: A Multicentre, Machine Learning, Deformation-Based Morphometry Study.Annals of neurology · 2025Article
- Cumulative incidence of motor and cognitive features in the amyotrophic lateral sclerosis-frontotemporal degeneration spectrum.Brain communications · 2025Article
- The Basis of Cognitive and Behavioral Dysfunction in Amyotrophic Lateral Sclerosis.Brain and behavior · 2024Review
- Ecological validity of performance-based cognitive screeners in amyotrophic lateral sclerosis: preliminary evidence.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2024Article
- Prevalence and motor-functional correlates of frontotemporal-spectrum disorders in a large cohort of non-demented ALS patients.Journal of neurology · 2024Article
- Prognostic Clinical and Biological Markers for Amyotrophic Lateral Sclerosis Disease Progression: Validation and Implications for Clinical Trial Design and Analysis.medRxiv : the preprint server for health sciences · 2024Article
- Cognitive reserve in ALS: the role of occupational skills and requirements.Amyotrophic lateral sclerosis & frontotemporal degeneration · 2024Article
- Temporal course of cognitive and behavioural changes in motor neuron diseases.Journal of neurology, neurosurgery, and psychiatry · 2024Article
- Frontotemporal-spectrum disorders and functional independence in non-demented ALS patients.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2024Article
- Novel data-driven subtypes and stages of brain atrophy in the ALS-FTD spectrum.Translational neurodegeneration · 2023Article
- The Spectrum of Cognitive Dysfunction in Amyotrophic Lateral Sclerosis: An Update.International journal of molecular sciences · 2023Review
- Data-driven neuropathological staging and subtyping of TDP-43 proteinopathies.Brain : a journal of neurology · 2023Article
- Prevalence and determinants of language impairment in non-demented amyotrophic lateral sclerosis patients.European journal of neurology · 2023Article
- Data-driven neuropathological staging and subtyping of TDP-43 proteinopathies.medRxiv : the preprint server for health sciences · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
21 authors at 10 institutions in 2 countries.
Corey T McMillanDepartment of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
Joanne WuuDepartment of Neurology, University of Miami Miller School of Medicine, Miami, FL, USA.
Katya RascovskyDepartment of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
Stephanie CosentinoThe Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University, New York, NY, USA.
Murray GrossmanDepartment of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.ORCID 0000-0002-7447-6218
Lauren ElmanDepartment of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
Colin QuinnDepartment of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.ORCID 0000-0003-0618-5854
Luis RosarioDepartment of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
Jessica H StarkDepartment of Neurology, University of Miami Miller School of Medicine, Miami, FL, USA.
Volkan GranitDepartment of Neurology, University of Miami Miller School of Medicine, Miami, FL, USA.
Hannah BriembergDivision of Neurology, Department of Medicine, University of British Columbia, Vancouver, Canada.
Sneha ChenjiDepartment of Clinical Neurosciences, Hotchkiss Brain Institute, University of Calgary, Calgary, Canada.ORCID 0000-0002-0635-1528
Annie DionneDepartment of Medicine, Université Laval, Canada.
Angela GengeMontreal Neurological Institute and Hospital, McGill University, Montreal, Canada.
Wendy JohnstonDivision of Neurology, Department of Medicine, University of Alberta, Edmonton, Canada, and.
Lawrence KorngutDepartment of Clinical Neurosciences, Hotchkiss Brain Institute, University of Calgary, Calgary, Canada.
Christen ShoesmithLondon Health Sciences Centre, Western University, London, Canada.
Lorne ZinmanSunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada.
Canadian ALS Neuroimaging Consortium (CALSNIC)
Sanjay KalraDivision of Neurology, Department of Medicine, University of Alberta, Edmonton, Canada, and.
Michael BenatarDepartment of Neurology, University of Miami Miller School of Medicine, Miami, FL, USA.ORCID 0000-0003-4241-5135
University of Pennsylvania · USUniversity of Miami · USUniversity of Alberta · CAUniversity of Calgary · CAColumbia University · USMontreal Neurological Institute and Hospital · CASunnybrook Health Science Centre · CAUniversité Laval · CAUniversity of British Columbia · CAWestern University · CA
Funding
Transgenic Mouse Models of Tau PathologiesP01AG017586 · NIA · UNIVERSITY OF PENNSYLVANIA · PI LEE, VIRGINIA M · 2000 to 2021
$37.3MResearch Education CoreP30AG066462 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Andrew Franklin Teich · 2020 to 2026
$30.1MUncovering new genes and disease modifiers for ALS and related disordersU54NS092091 · NINDS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Michael Benatar · 2014 to 2026
$19.8MUnderstanding Environmental Contributions to Heterogeneity in bvFTD.P01AG066597 · NIA · UNIVERSITY OF PENNSYLVANIA · PI David John Irwin, Corey T McMillan · 2020 to 2026
$18.8MMulti-Center ALS Biomarker Validation Study (CReATe Biomarkers)U01NS107027 · NINDS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI BENATAR, MICHAEL, MALASPINA, ANDREA · 2018 to 2023
$3.5MPre-Symptomatic Familial ALS (Pre-fALS) Study - Prelude to a Treatment Trial; Administrative SupplementR01NS105479 · NINDS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI BENATAR, MICHAEL, WUU, JOANNE · 2018 to 2022
$3.0MCIHRNIA NIH HHS P01 AG017586NIA NIH HHS P01 AG066597NIA NIH HHS P30 AG066462NINDS NIH HHS R01 NS105479NINDS NIH HHS U01 NS107027NINDS NIH HHS U54 NS092091
Abstract
PubMed holds no abstract for this paper.
Indexed as
Amyotrophic Lateral SclerosisCognitive DysfunctionAdultCognitionCross-Sectional StudiesEducational StatusHumansNeuropsychological TestsALS-FTDbiomarkerCognitiondementiaECASneuropsychologynormative datarisk
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.